NRX Pharmaceuticals Inc. (NRXP)
NASDAQ · Healthcare
NRX Pharmaceuticals Inc. Income Statement 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 1.2M | 0 | 0 |
| Gross Profit | 720,000 | 0 | — |
| Profitability | |||
| Operating Income | -16.2M | -18.5M | -27.8M |
| EBITDA | -16.2M | -18.5M | — |
| Net Income | -28.6M | -25.1M | -30.1M |
| Per Share Data | |||
| EPS (diluted) | — | — | — |
| Shares Outstanding (dil.) | 32M | 15M | 8M |
NRX Pharmaceuticals Inc. Income Statement — FAQ
NRX Pharmaceuticals Inc. (NRXP) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NRXP's income statement history?
The chart and table above show NRX Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.